Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Aug 15, 2025; 17(8): 105818
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.105818
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.105818
Table 3 Summary of tumor microvessel densities in patients
Time period | High microvascular density (%) | Low microvascular density (%) | Medium microvascular density (%) | Total (%) | F value | P value |
Before treatment | 72.50 ± 4.23 | 14.25 ± 3.65 | 13.25 ± 3.45 | 72.50 ± 4.23 | ||
1 month after treatment | 60.00 ± 5.12 | 22.50 ± 4.43 | 17.50 ± 4.25 | 60.00 ± 5.12 | 5.784 | 0.019 |
3 months after treatment | 50.25 ± 5.89 | 28.00 ± 4.95 | 21.75 ± 5.12 | 50.25 ± 5.89 | 7.450 | 0.008 |
6 months after treatment | 40.00 ± 4.50 | 35.00 ± 5.45 | 25.00 ± 4.92 | 40.00 ± 4.50 | 9.236 | 0.003 |
- Citation: Chen LP, Dong Y, He JG, Yang QQ, Hu ZW. Contrast-enhanced ultrasound in evaluating the curative effect of interventional therapy in patients with liver cancer. World J Gastrointest Oncol 2025; 17(8): 105818
- URL: https://www.wjgnet.com/1948-5204/full/v17/i8/105818.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i8.105818